China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD

Clinical trial NCT06666413 · RECRUITING

Trial details

NCT number: NCT06666413
Sponsor: Genzyme, a Sanofi Company
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Glycogen Storage Disease Type II Pompe's Disease

Start date: 2025-05-07
Primary completion: 2028-05-02
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.